Research in Medical and Dental Sciences We are dedicated to performing world-leading research with the ultimate goal of improving human health.
Research Childhood Cancer Trial Bayer to invest in multi-millionaire-pound trial at the University of Birmingham
COVID-19 Research and News from the College All the latest coronavirus research developments, news and comment from the College of Medical and Dental Sciences
Posted 04 June 2021 Study of UK dental professionals reveals extent of occupational risk of SARS-CoV-2 infection A University of Birmingham-led study of over a thousand dental professionals has shown their increased occupational risk of SARS-CoV-2 infection during the first wave of the pandemic in the UK.
Posted 04 June 2021 Many patients with COVID-19 produce immune responses against their body's own tissues or organs, finds study A University of Birmingham-led study funded by the UK Coronavirus Immunology Consortium has found that many patients with COVID-19 produce immune responses against their body's own tissues or organs.
Posted 14 May 2021 Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in older people, finds study New study finds that antibody response in people over 80 is three-and-a-half times greater in those who have the second dose of the Pfizer COVID-19 vaccine after 12 weeks compared to at a three-week interval.
Posted 14 May 2021 New study into paediatric intensive care paves the way for improving care for critically ill children A new study carried out in collaboration with the University of Birmingham has identified factors that increase the likelihood of critically ill children needing life-saving CPR.
Posted 13 May 2021 NEC Laboratories Europe supports University of Birmingham-based InHANSE's innovative clinical cancer research NEC Laboratories Europe has announced a donation to the University of Birmingham-based Institute of Head and Neck Studies and Education (InHANSE) to support its future cancer research.
Posted 12 May 2021 Better treatment for miscarriage patients is more cost effective than current standard NHS treatment, study finds A new drug combination is both better at treating miscarriage and more cost effective than current standard NHS treatment, finds a new study
Posted 12 May 2021 Study launches to investigate immune response to SARS-CoV-2 infection in patients with antibody deficiencies A new study aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody deficiency.
Posted 11 May 2021 Funding awarded for five new innovative clean air projects The University of Birmingham-led TRANSITION Clean Air Network today announces it is funding five new research projects aimed at improving air quality by reducing harmful transport emissions.
Posted 11 May 2021 Agents that target viral RNA could be the basis for next generation broad spectrum anti-viral drugs– new study A new approach to tackling viruses by targeting the 'control centre' in viral RNA could lead to broad spectrum anti-viral drugs and provide a first line of defence against future pandemics, according to new research.
Posted 10 May 2021 Bayer to invest in childhood cancer trial at the University of Birmingham Significant funding from Bayer enables the University of Birmingham to deliver a new study arm of an international clinical trial which aims to identify more effective treatments for a rare type of childhood cancer.
Posted 06 May 2021 Better access to dental care could help Brazil win battle against COPD Oral health in Brazil needs better promotion and more accessible public dental services, in order to help tackle the impact of Chronic Obstructive Pulmonary Disease.